Eligibility: Applicants for P30 P&F funding are limited to individuals with an independent faculty appointment. High quality proposals are invited from investigators at Emory, Georgia Tech, Morehouse School of Medicine, Georgia State University, University of Georgia, and Augusta University. Eligible investigators generally fall into one of the three following categories:
- Junior faculty without significant CF grant support (i.e., an NIH R01).
- Established scientists with no previously funded work in CF, who wish to apply their expertise to a problem in this area.
- Experienced CF investigators who propose testing innovative ideas that represent a clear departure from their established research program.
Desired features of P30 pilots: Projects should reflect overall research goals of the Georgia CF Core Center. Areas of emphasis include molecular mechanisms of CF pathogenesis, CF‐related diabetes (CFRD), CF‐related liver disease (CFLD), gastrointestinal complications, diet/nutrition, role or impact of exercise, or other topics relevant to the NIDDK P30 mechanism. Note: Projects focused on strictly pulmonary aspects of CF will not be considered, unless tied to NIDDK‐relevant complications of CF (e.g., CFRD).
Current Opportunity
Eligible investigators are invited to submit a Letter of Intent (LOI) that will be reviewed by the GACF P30 P&F Program Committee. Investigators with the highest quality LOIs will be invited to submit a full proposal, which will be formatted similar to an NIH R21. Full proposals will be evaluated by both internal and external consultants using standard NIH criteria.
Submit a LOI
